Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 151 articles: HTML format Text format

Single Articles

July 2018
1. MAKWANA A, Sheppard C, Borrow R, Fry N, et al
   Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
   Pediatr Infect Dis J. 2018;37:697-703.
   PubMed     Text format     Abstract available
   
   
   June 2018
2. KADLECEK V, Borja-Tabora CF, Eder-Lingelbach S, Gatchalian S, et al
   Antibody Persistence up to 3 Years after Primary Immunization with Inactivated Japanese Encephalitis Vaccine IXIARO(R) in Philippine Children and Effect of a Booster Dose.
   Pediatr Infect Dis J. 2018 Jun 15. doi: 10.1097/INF.0000000000002124.
   PubMed     Text format     Abstract available
   
   
   
3. 
   Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: ERRATUM.
   Pediatr Infect Dis J. 2018;37:611.
   PubMed     Text format    
   
   
   May 2018
4. PRYMULA R, Kieninger D, Feroldi E, Jordanov E, et al
   Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
   Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000002109.
   PubMed     Text format     Abstract available
   
   
   
5. MOODLEY K, Coovadia YM, Cohen C, Meiring S, et al
   Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003 - 2008.
   Pediatr Infect Dis J. 2018 May 4. doi: 10.1097/INF.0000000000002096.
   PubMed     Text format     Abstract available
   
   
   
6. 
   Vaccination in Pregnancy-Recent Developments: ERRATUM.
   Pediatr Infect Dis J. 2018;37:465.
   PubMed     Text format    
   
   
   
7. 
   Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy: ERRATUM.
   Pediatr Infect Dis J. 2018;37:450.
   PubMed     Text format    
   
   
   April 2018
8. NAZIAT H, Saha S, Islam M, Saha S, et al
   Epidemiology of Otitis Media with Otorrhea Among Bangladeshi Children: Baseline Study for Future Assessment of Pneumococcal Conjugate Vaccine Impact.
   Pediatr Infect Dis J. 2018 Apr 9. doi: 10.1097/INF.0000000000002077.
   PubMed     Text format     Abstract available
   
   
   March 2018
9. GETACHEW HB, Dahl RM, Lopman BA, Parashar UD, et al
   Rotavirus Vaccines and Health Care Utilization for Diarrhea in US Children, 2001-2015.
   Pediatr Infect Dis J. 2018 Mar 14. doi: 10.1097/INF.0000000000001988.
   PubMed     Text format     Abstract available
   
   
   
10. OH CE, Choi UY, Eun BW, Lee TJ, et al
    A Randomized, Double-Blind, Active-Controlled Clinical Trial of a Cell Culture-Derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age.
    Pediatr Infect Dis J. 2018 Mar 9. doi: 10.1097/INF.0000000000001973.
    PubMed     Text format     Abstract available
    
    
    
11. JACOBS K, Posa M, Spellicy W, Otero J, et al
    Adult Caregiver Influenza Vaccination Through Administration in Pediatric Outpatient Clinics: A Cocooning Healthcare Improvement Project.
    Pediatr Infect Dis J. 2018 Mar 2. doi: 10.1097/INF.0000000000001970.
    PubMed     Text format     Abstract available
    
    
    February 2018
12. NEUZIL KM
    Quantifying the Impact of Maternal Influenza Vaccination: Beyond Laboratory-Confirmed Efficacy.
    Pediatr Infect Dis J. 2018 Feb 24. doi: 10.1097/INF.0000000000001967.
    PubMed     Text format    
    
    
    
13. UBUKATA K, Morozumi M, Sakuma M, Takata M, et al
    Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates after Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children.
    Pediatr Infect Dis J. 2018 Feb 22. doi: 10.1097/INF.0000000000001956.
    PubMed     Text format     Abstract available
    
    
    
14. LI-KIM-MOY J, Wood N, Jones C, Macartney K, et al
    Impact of Fever and Antipyretic Use on Influenza Vaccine Immune Reponses in Children.
    Pediatr Infect Dis J. 2018 Feb 19. doi: 10.1097/INF.0000000000001949.
    PubMed     Text format     Abstract available
    
    
    
15. MASSEY J, Nair A, Dietz S, Snaman D, et al
    Hospital, Maternal, and Birth Factors Associated with Hepatitis B Vaccination at Birth - West Virginia, 2015.
    Pediatr Infect Dis J. 2018 Feb 16. doi: 10.1097/INF.0000000000001953.
    PubMed     Text format     Abstract available
    
    
    
16. KAORU H, Igarashi R, Hoshina T, Kojiro M, et al
    Utility of the Performance of Lumbar Puncture for Febrile Children with Status Epilepticus in the Bacterial Conjugate Vaccine Era.
    Pediatr Infect Dis J. 2018 Feb 15. doi: 10.1097/INF.0000000000001945.
    PubMed     Text format     Abstract available
    
    
    
17. TELJEUR C, Moran PS, Harrington P, Butler K, et al
    Economic Evaluation of Selective Neonatal BCG Vaccination of High-Risk Infants in Ireland.
    Pediatr Infect Dis J. 2018 Feb 9. doi: 10.1097/INF.0000000000001891.
    PubMed     Text format     Abstract available
    
    
    
18. WITTE D, Cunliffe NA, Turner AM, Ngulube E, et al
    Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
    Pediatr Infect Dis J. 2018 Feb 9. doi: 10.1097/INF.0000000000001937.
    PubMed     Text format     Abstract available
    
    
    
19. HAVERS FP, Fry AM, Peacock G, Chen J, et al
    Influenza Vaccination Coverage in Children with Neurologic Disorders and Their Siblings, July 2006-June 2014.
    Pediatr Infect Dis J. 2018 Feb 7. doi: 10.1097/INF.0000000000001929.
    PubMed     Text format     Abstract available
    
    
    
20. LIN L, Parra MM, Sierra VY, Cespedes AS, et al
    Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine in 4-6 Year-Old Girls: Results to Month 12 from a Randomized Trial.
    Pediatr Infect Dis J. 2018 Feb 7. doi: 10.1097/INF.0000000000001871.
    PubMed     Text format     Abstract available
    
    
    
21. DAHL RM, Curns AT, Tate JE, Parashar UD, et al
    Effect of Rotavirus Vaccination on Acute Diarrheal Hospitalizations Among Low and Very Low Birth Weight US Infants, 2001-2015.
    Pediatr Infect Dis J. 2018 Feb 3. doi: 10.1097/INF.0000000000001930.
    PubMed     Text format     Abstract available
    
    
    January 2018
22. BURKE RM, Tate JE, Pringle KD, Patel M, et al
    Effect of Age at Vaccination on Rotavirus Vaccine Effectiveness in Bolivian Infants.
    Pediatr Infect Dis J. 2018 Jan 16. doi: 10.1097/INF.0000000000001907.
    PubMed     Text format     Abstract available
    
    
    
23. SZENBORN L, Block SL, Jackowska T, Konior R, et al
    Immune Responses to Booster Vaccination with Meningococcal ABCWY Vaccine Following Primary Vaccination with Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
    Pediatr Infect Dis J. 2018 Jan 11. doi: 10.1097/INF.0000000000001896.
    PubMed     Text format     Abstract available
    
    
    
24. CUNNINGHAM-ERVES JL, Kelly-Taylor KD, Mayo-Gamble TL, Deakings JA, et al
    A Physician's Recommendation for HPV Vaccination: What Makes African American Mothers Compliant?
    Pediatr Infect Dis J. 2018 Jan 11. doi: 10.1097/INF.0000000000001906.
    PubMed     Text format     Abstract available
    
    
    
25. TRUCK J, Kelly S, Jawad S, Snape MD, et al
    Differences in Immunization Site Pain in Toddlers Vaccinated with Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine.
    Pediatr Infect Dis J. 2018 Jan 10. doi: 10.1097/INF.0000000000001894.
    PubMed     Text format     Abstract available
    
    
    
26. BLACK S
    Editor's Commentary: Vaccines as a Tool to Combat Antibiotic Resistance.
    Pediatr Infect Dis J. 2018;37:96.
    PubMed     Text format    
    
    
    
27. ALFONSO VH, Doshi RH, Mukadi P, Higgins SG, et al
    Prevalence of Rubella Antibodies Among Children in the Democratic Republic of the Congo.
    Pediatr Infect Dis J. 2018;37:28-34.
    PubMed     Text format     Abstract available
    
    
    
28. NDUBA V, Van't Hoog AH, Mitchell EMH, Borgdorff M, et al
    Incidence of Active Tuberculosis and Cohort Retention Among Adolescents in Western Kenya.
    Pediatr Infect Dis J. 2018;37:10-15.
    PubMed     Text format     Abstract available
    
    
    December 2017
29. EYTHORSSON E, Hrafnkelsson B, Erlendsdottir H, Atli Gudmundsson S, et al
    Decreased AOM with Treatment Failure Following Introduction of the Ten-Valent Pneumococcal Haemophilus influenzae Protein D Conjugate Vaccine.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001870.
    PubMed     Text format     Abstract available
    
    
    
30. BROPHY J, Bitnun A, Alimenti A, Lapointe N, et al
    Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living with HIV.
    Pediatr Infect Dis J. 2017 Dec 22. doi: 10.1097/INF.0000000000001874.
    PubMed     Text format     Abstract available
    
    
    
31. BADAHDAH AM, Khatami A, Tashani M, Rashid H, et al
    Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001861.
    PubMed     Text format     Abstract available
    
    
    
32. RYBAK A, Levy C, Bonacorsi S, Bechet S, et al
    Antibiotic Resistance of Potential Otopathogens Isolated from Nasopharyngeal Flora of Children with Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Pediatr Infect Dis J. 2017 Dec 8. doi: 10.1097/INF.0000000000001862.
    PubMed     Text format     Abstract available
    
    
    
33. PALMU AA, Lahdenkari M
    Early Vaccine-Type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared to Early Acute Otitis Media Due to Other Bacterial Etiology.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001851.
    PubMed     Text format     Abstract available
    
    
    
34. LU CY, Tsai HC, Huang YC, Huang DT, et al
    A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan.
    Pediatr Infect Dis J. 2017;36:e307-e312.
    PubMed     Text format     Abstract available
    
    
    November 2017
35. SANTOS VS, Nobrega FA, Soares MWS, Moreira RD, et al
    Rotavirus Genotypes Circulating in Brazil Before and After the National Rotavirus Vaccine Program: A Review.
    Pediatr Infect Dis J. 2017 Nov 17. doi: 10.1097/INF.0000000000001770.
    PubMed     Text format     Abstract available
    
    
    
36. HEININGER U
    Is There A Need For A Stand-Alone Acellular Pertussis Vaccine?
    Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001767.
    PubMed     Text format    
    
    
    
37. MOKOMANE M, Tate JE, Steenhoff AP, Esona MD, et al
    Evaluation of the Influence of Gastrointestinal Co-Infections on Rotavirus Vaccine Effectiveness in Botswana.
    Pediatr Infect Dis J. 2017 Nov 16. doi: 10.1097/INF.0000000000001828.
    PubMed     Text format     Abstract available
    
    
    
38. SUCCI RC, Krauss MR, Harris DR, Machado DM, et al
    Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001831.
    PubMed     Text format     Abstract available
    
    
    
39. JONES CE, Calvert A, Le Doare K
    Vaccination in Pregnancy - Recent Developments.
    Pediatr Infect Dis J. 2017 Nov 11. doi: 10.1097/INF.0000000000001822.
    PubMed     Text format    
    
    
    
40. LIVNI G, Wainstein A, Birk E, Chodick G, et al
    Influenza Vaccination Rate and Reasons for Nonvaccination in Children With Cardiac Disease.
    Pediatr Infect Dis J. 2017;36:e268-e271.
    PubMed     Text format     Abstract available
    
    
    October 2017
41. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
    Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Programme on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
    Pediatr Infect Dis J. 2017 Oct 28. doi: 10.1097/INF.0000000000001810.
    PubMed     Text format     Abstract available
    
    
    
42. GARRIDO-GARCIA LM, Castillo-Moguel A, Vazquez-Rivera M, Cravioto P, et al
    Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
    Pediatr Infect Dis J. 2017;36:e237-e241.
    PubMed     Text format     Abstract available
    
    
    September 2017
43. ARYA BK, Bhattacharya SD, Sutcliffe CG, Ganaie F, et al
    Nasopharyngeal pneumococcal colonization and impact of a single dose of 13-valent pneumococcal conjugate vaccine in Indian children with HIV and their unvaccinated parents.
    Pediatr Infect Dis J. 2017 Sep 27. doi: 10.1097/INF.0000000000001800.
    PubMed     Text format     Abstract available
    
    
    
44. BERNAOLA E, Gil F, Herranz M, Gil-Setas A, et al
    Pneumococcal Vaccination and Pneumonia Associated with Pleural Effusion in a Pediatric Population.
    Pediatr Infect Dis J. 2017 Sep 20. doi: 10.1097/INF.0000000000001798.
    PubMed     Text format     Abstract available
    
    
    
45. BAXTER RP, Lewis N, Fireman B, Hansen J, et al
    Live Attenuated Influenza Vaccination Prior To Age 3 Years and Subsequent Development of Asthma: A 14-Year Follow-Up Study.
    Pediatr Infect Dis J. 2017 Sep 12. doi: 10.1097/INF.0000000000001783.
    PubMed     Text format     Abstract available
    
    
    
46. MALTEZOU HC, Pavli A, Theodoridou K, Katerelos P, et al
    Vaccinations and Malaria Chemoprophylaxis of Adolescents Traveling from Greece to International Destinations: A Nine-Year Prospective Study.
    Pediatr Infect Dis J. 2017 Sep 6. doi: 10.1097/INF.0000000000001782.
    PubMed     Text format     Abstract available
    
    
    August 2017
47. FIORITO TM, Baird GL, Alexander-Scott N, Bornschein S, et al
    Adverse Events Following Vaccination with Bivalent rLP2086 (Trumenba(R)): An Observational, Longitudinal Study During a College Outbreak and a Systematic Review.
    Pediatr Infect Dis J. 2017 Aug 19. doi: 10.1097/INF.0000000000001742.
    PubMed     Text format     Abstract available
    
    
    
48. DIONNE-ODOM J, Westfall AO, Nzuobontane D, Vinikoor MJ, et al
    Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.
    Pediatr Infect Dis J. 2017 Aug 2. doi: 10.1097/INF.0000000000001728.
    PubMed     Text format     Abstract available
    
    
    July 2017
49. ROSENBLUT A, Rosenblut M, Garcia K, Maul X, et al
    Frequency of Acute Otitis Media in Children Under 24 Months of Age Before and After the Introduction of the 10-Valent Pneumococcal Conjugate Vaccine Into the National Immunization Program in Chile.
    Pediatr Infect Dis J. 2017 Jul 31. doi: 10.1097/INF.0000000000001722.
    PubMed     Text format     Abstract available
    
    
    
50. PALMU AA, Toropainen M, Kaijalainen T, Siira L, et al
    Direct and Indirect Effectiveness of the Ten-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster-Randomized Trial.
    Pediatr Infect Dis J. 2017 Jul 21. doi: 10.1097/INF.0000000000001705.
    PubMed     Text format     Abstract available
    
    
    
51. RICKETSON LJ, Conradi NG, Vanderkooi OG, Kellner JD, et al
    Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children, Before and After the 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.
    Pediatr Infect Dis J. 2017 Jul 20. doi: 10.1097/INF.0000000000001709.
    PubMed     Text format     Abstract available
    
    
    
52. SINGLETON R, Seeman S, Grinnell M, Bulkow L, et al
    Trends in Otitis Media and Myringotomy with Tube Placement among American Indian and Alaska Native Children and the U.S. General Population of Children after Introduction of the 13-valent Pneumococcal Conjugate Vaccine.
    Pediatr Infect Dis J. 2017 Jul 19. doi: 10.1097/INF.0000000000001704.
    PubMed     Text format     Abstract available
    
    
    
53. MCAULIFFE GN, Taylor SL, Drinkovic D, Roberts SA, et al
    Rotavirus Infection in the Auckland Region Following the Implementation of Universal Infant Rotavirus Vaccination: Impact on Hospitalisations and Laboratory Implications.
    Pediatr Infect Dis J. 2017 Jul 19. doi: 10.1097/INF.0000000000001706.
    PubMed     Text format     Abstract available
    
    
    
54. OLARTE L, Romero J, Barson W, Bradley J, et al
    Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post Pneumococcal Conjugate Vaccine Era.
    Pediatr Infect Dis J. 2017 Jul 18. doi: 10.1097/INF.0000000000001697.
    PubMed     Text format     Abstract available
    
    
    
55. AGARKHEDKAR S, Juergens C, Balasundaram K, Agarkhedkar S, et al
    Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children Aged 6 to 17 Years in India: An Open-Label Trial.
    Pediatr Infect Dis J. 2017 Jul 15. doi: 10.1097/INF.0000000000001695.
    PubMed     Text format     Abstract available
    
    
    
56. TARTOF SY, Sy LS, Ackerson BK, Hechter RC, et al
    Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years.
    Pediatr Infect Dis J. 2017 Jul 14. doi: 10.1097/INF.0000000000001696.
    PubMed     Text format     Abstract available
    
    
    
57. LOPEZ P, Mohs AA, Vasquez AA, Consuelo-Miranda M, et al
    A Randomized, Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
    Pediatr Infect Dis J. 2017 Jul 14. doi: 10.1097/INF.0000000000001682.
    PubMed     Text format     Abstract available
    
    
    June 2017
58. PIREZ MC, Mota MI, Giachetto G, Varela MS, et al
    Pneumococcal Meningitis Before and After Universal Vaccination with Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Non Public Institutions, in Uruguay.
    Pediatr Infect Dis J. 2017 Jun 28. doi: 10.1097/INF.0000000000001671.
    PubMed     Text format     Abstract available
    
    
    
59. GISSELSSON-SOLEN M
    Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination; A National Observational Study.
    Pediatr Infect Dis J. 2017 Jun 27. doi: 10.1097/INF.0000000000001654.
    PubMed     Text format     Abstract available
    
    
    
60. CHO YC, Chiu NC, Lu CY, Huang DT, et al
    Redistribution of Streptococcus pneumoniae Serotypes after Nationwide 13-Valent Pneumococcal Conjugate Vaccine Program in Children in Northern Taiwan.
    Pediatr Infect Dis J. 2017 Jun 22. doi: 10.1097/INF.0000000000001664.
    PubMed     Text format     Abstract available
    
    
    
61. MUJURU HA, Yen C, Nathoo KJ, Gonah NA, et al
    Reduction in Diarrhea- and Rotavirus-related Healthcare Visits among Children <5 Years of Age Following National Rotavirus Vaccine Introduction in Zimbabwe.
    Pediatr Infect Dis J. 2017 Jun 20. doi: 10.1097/INF.0000000000001648.
    PubMed     Text format     Abstract available
    
    
    
62. YEN C, Shih SM, Tate JE, Wu FT, et al
    Intussusception-related Hospitalizations among Infants before and after Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.
    Pediatr Infect Dis J. 2017 Jun 17. doi: 10.1097/INF.0000000000001644.
    PubMed     Text format     Abstract available
    
    
    
63. WATANABE M, Ochiai H, Ito M, Negoro M, et al
    Laboratory Diagnosis of Breakthrough Varicella in Children.
    Pediatr Infect Dis J. 2017;36:560-563.
    PubMed     Text format     Abstract available
    
    
    May 2017
64. BASSAL R, Weil M, Cohen D, Sofer D, et al
    Seroprevalence of Hepatitis A 12-years Following the Implementation of Toddlers' Vaccination: A Population Based Study in Israel.
    Pediatr Infect Dis J. 2017 May 11. doi: 10.1097/INF.0000000000001640.
    PubMed     Text format     Abstract available
    
    
    
65. SIRIMA SB, Tiono A, Gansane Z, Siribie M, et al
    Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
    Pediatr Infect Dis J. 2017;36:e136-e150.
    PubMed     Text format     Abstract available
    
    
    
66. RIISE OR, Laake I, Vestrheim D, Flem E, et al
    Risk of Pertussis in Relation to Degree of Prematurity in Children Less Than 2 Years of Age.
    Pediatr Infect Dis J. 2017;36:e151-e156.
    PubMed     Text format     Abstract available
    
    
    
67. HENAFF F, Levy C, Cohen R, Picard C, et al
    Risk Factors in Children Older Than 5 Years With Pneumococcal Meningitis: Data From a National Network.
    Pediatr Infect Dis J. 2017;36:457-461.
    PubMed     Text format     Abstract available
    
    
    April 2017
68. DUBISCHAR KL, Kadlecek V, Sablan B Jr, Borja-Tabora CF, et al
    Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO(R) in Children - an Open-Label, Randomized, Active-Controlled, Phase 3 Study.
    Pediatr Infect Dis J. 2017 Apr 24. doi: 10.1097/INF.0000000000001623.
    PubMed     Text format     Abstract available
    
    
    
69. VAN DER LEE S, Kemmeren JM, de Rond LGH, Ozturk K, et al
    Elevated Immune Response Among Children 4 Years Of Age With Pronounced Local Adverse Events After The Fifth Dtap Vaccination.
    Pediatr Infect Dis J. 2017 Apr 19. doi: 10.1097/INF.0000000000001620.
    PubMed     Text format     Abstract available
    
    
    
70. DUBISCHAR KL, Kadlecek V, Sablan B Jr, Borja-Tabora CF, et al
    Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO(R) n Children from a Japanese Encephalitis Virus -Endemic Region.
    Pediatr Infect Dis J. 2017 Apr 19. doi: 10.1097/INF.0000000000001615.
    PubMed     Text format     Abstract available
    
    
    
71. OUTI V, Jukka J, Mika L, Tuija L, et al
    Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001600.
    PubMed     Text format     Abstract available
    
    
    
72. MAERTENS K, Burbidge P, Van Damme P, Goldblatt D, et al
    Pneumococcal Immune Response in Infants Whose Mothers Received Tdap Vaccination During Pregnancy.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001601.
    PubMed     Text format     Abstract available
    
    
    
73. BRUIJNING-VERHAGEN P, Groome M
    Rotavirus Vaccine - Current Use and Future Considerations.
    Pediatr Infect Dis J. 2017 Apr 5. doi: 10.1097/INF.0000000000001594.
    PubMed     Text format    
    
    
    March 2017
74. GOUVEIA M, Fiorentino F, Jesus G, Costa J, et al
    Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal.
    Pediatr Infect Dis J. 2017 Mar 10. doi: 10.1097/INF.0000000000001587.
    PubMed     Text format     Abstract available
    
    
    
75. MACDONALD-LAURS E, Ganeshalingham A, Lillie J, McSharry B, et al
    Increasing Incidence of Life-threatening Pertussis: A Retrospective Cohort Study in New Zealand.
    Pediatr Infect Dis J. 2017;36:282-289.
    PubMed     Text format     Abstract available
    
    
    
76. SMITH MJ, Jordanov E, Sheng X, Tsang PH, et al
    Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age.
    Pediatr Infect Dis J. 2017;36:319-325.
    PubMed     Text format     Abstract available
    
    
    February 2017
77. SEDERDAHL BK, Yi J, Jerris R, Gillespie SE, et al
    The Residual Vaccine-Preventable Burden of Rotavirus Disease.
    Pediatr Infect Dis J. 2017 Feb 15. doi: 10.1097/INF.0000000000001580.
    PubMed     Text format     Abstract available
    
    
    
78. LIVNI G, Wainstein A, Birk E, Chodick G, et al
    Influenza Vaccination Rate and Reasons for Non-Vaccination in Children with Cardiac Disease.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001579.
    PubMed     Text format     Abstract available
    
    
    
79. CHRISTELLE TX, Min CS, Lee LY, Ong C, et al
    Serologic Responses After Hepatitis B Vaccination in Preterm Infants Born to Hepatitis B Surface Antigen Positive Mothers: Singapore Experience.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001578.
    PubMed     Text format     Abstract available
    
    
    
80. NEWMAN LP, Njoroge A, Magaret A, Chohan BH, et al
    Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001572.
    PubMed     Text format     Abstract available
    
    
    
81. LE MARECHAL M, Agrinier N, Fressard L, Verger P, et al
    Low Uptake of Meningococcal C Vaccination in France: A Cross-Sectional Nationwide Survey of General Practitioners' Perceptions, Attitudes and Practices.
    Pediatr Infect Dis J. 2017 Feb 3. doi: 10.1097/INF.0000000000001553.
    PubMed     Text format     Abstract available
    
    
    
82. POYHONEN L, Kroger L, Huhtala H, Makinen J, et al
    Association of MBL2, TLR1, TLR2 and TLR6 Polymorphisms With Production of IFN-gamma and IL-12 in BCG Osteitis Survivors R1.
    Pediatr Infect Dis J. 2017;36:135-139.
    PubMed     Text format     Abstract available
    
    
    January 2017
83. MARTINON-TORRES F, Dionne M, Greenberg D, Varman M, et al
    Safety, Tolerability, and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process.
    Pediatr Infect Dis J. 2017 Jan 27. doi: 10.1097/INF.0000000000001511.
    PubMed     Text format     Abstract available
    
    
    
84. PINTO M, Dawar M, Krajden M, Naus M, et al
    Will Infant Hepatitis B Vaccination Protect into Adulthood? Extended Canadian Experience After a 2, 4, 6 Month Immunization Schedule.
    Pediatr Infect Dis J. 2017 Jan 26. doi: 10.1097/INF.0000000000001543.
    PubMed     Text format     Abstract available
    
    
    
85. CHUN CHAU JP, Lo SH, Chow Choi K, Kin Chau MH, et al
    Factors Determining the Uptake of Influenza Vaccination Among Children with Chronic Conditions.
    Pediatr Infect Dis J. 2017 Jan 19. doi: 10.1097/INF.0000000000001550.
    PubMed     Text format     Abstract available
    
    
    
86. KUROSKY SK, Davis KL, Galindo CM
    Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States.
    Pediatr Infect Dis J. 2017 Jan 17. doi: 10.1097/INF.0000000000001548.
    PubMed     Text format     Abstract available
    
    
    
87. RODRIGUEZ MELO FI, Morales JJ, De Los Santos AH, Rivas E, et al
    Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim(R)) Administered Concomitantly with Tetravalent Dengue Vaccine in Healthy Toddlers Aged 15 to 18 Months in Mexico: A Randomized Trial.
    Pediatr Infect Dis J. 2017 Jan 6. doi: 10.1097/INF.0000000000001542.
    PubMed     Text format     Abstract available
    
    
    
88. LI F, Hu Y, Zhou Y, Chen L, et al
    A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
    Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001535.
    PubMed     Text format     Abstract available
    
    
    December 2016
89. KOSALARAKSA P, Watanaveeradej V, Pancharoen C, Capeding MR, et al
    Long-Term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001494.
    PubMed     Text format     Abstract available
    
    
    
90. SIRIMA SB, Tiono A, Gansane Z, Siribie M, et al
    Immunogenicity and Safety Of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children with Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001518.
    PubMed     Text format     Abstract available
    
    
    
91. DE WALS P, Zhou Z
    Cost-Effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001512.
    PubMed     Text format     Abstract available
    
    
    
92. TRUCK J, Mitchell R, Jawad S, Clutterbuck EA, et al
    Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.
    Pediatr Infect Dis J. 2016 Dec 23. doi: 10.1097/INF.0000000000001497.
    PubMed     Text format     Abstract available
    
    
    
93. MERINO ARRIBAS JM, Carmona Martinez A, Horn M, Porcuna XM, et al
    Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Co-Administered with Routine Childhood Vaccines in European Infants: An Open, Randomized Trial.
    Pediatr Infect Dis J. 2016 Dec 19. doi: 10.1097/INF.0000000000001484.
    PubMed     Text format     Abstract available
    
    
    
94. MARCHISIO P, Esposito S, Picca M, Baggi E, et al
    Serotypes not Included in 13-Valent Pneumococcal Vaccine as Causes of Acute Otitis Media with Spontaneous Tympanic Membrane Perforation in a Geographic Area with High Vaccination Coverage.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001485.
    PubMed     Text format     Abstract available
    
    
    
95. BECKER-DREPS S, Vilchez S, Bucardo F, Twitchell E, et al
    The Association Between Fecal Biomarkers of Environmental Enteropathy and Rotavirus Vaccine Response in Nicaraguan Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available
    
    
    
96. LEE AM, Burns JC, Tremoulet AH
    Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
97. MARTINON-TORRES F, Wysocki J, Center KJ, Czajka H, et al
    Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared with Term Infants.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available
    
    
    
98. ZHANG L, Yang P, Thompson MG, Pan Y, et al
    Influenza Vaccine Effectiveness in Preventing Influenza Illness Among Children During School-Based Outbreaks in the 2014-2015 Season in Beijing, China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available
    
    
    
99. MAROM T, Peretz SB, Schwartz O, Goldfarb A, et al
    Impact of Pneumococcal Conjugate Vaccines on Selected Head and Neck Infections in Hospitalized Israeli Children.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available
    
    
    
100. HARRIS SL, Donald RG, Hawkins JC, Tan C, et al
     Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
101. SRICHAROENCHAI S, Lapphra K, Chuenkitmongkol S, Phongsamart W, et al
     Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination with Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
102. BLOCK SL, Klein NP, Sarpong K, Russell S, et al
     Lot-to-Lot Consistency, Safety, Tolerability, and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
103. VESIKARI T, Becker T, Vertruyen AF, Poschet K, et al
     A Phase III Randomized, Double-Blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at 2, 3, 4, and 12 Months.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
104. AABY P, Ravn H, Benn CS
     The WHO Review of the Possible Nonspecific Effects of Diphtheria-Tetanus-Pertussis Vaccine.
     Pediatr Infect Dis J. 2016;35:1247-1257.
     PubMed     Text format     Abstract available
     
     
     
105. MO X, Gai Tobe R, Liu X, Mori R, et al
     Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
     Pediatr Infect Dis J. 2016;35:e353-e361.
     PubMed     Text format     Abstract available
     
     
     
106. BETTINGER JA, Vanderkooi OG, Scheifele DW, Halperin SA, et al
     Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.
     Pediatr Infect Dis J. 2016;35:1242-1246.
     PubMed     Text format     Abstract available
     
     
     
107. AABY P, Ravn H, Benn CS, Rodrigues A, et al
     Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.
     Pediatr Infect Dis J. 2016;35:1232-1241.
     PubMed     Text format     Abstract available
     
     
     
108. SMEDEGAARD LM, Poulsen A, Kristensen IA, Rosthoj S, et al
     Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience.
     Pediatr Infect Dis J. 2016;35:e348-e352.
     PubMed     Text format     Abstract available
     
     
     
109. ARYA BK, Bhattacharya SD, Sutcliffe CG, Kumar Niyogi S, et al
     Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India.
     Pediatr Infect Dis J. 2016;35:e339-e347.
     PubMed     Text format     Abstract available
     
     
     October 2016
110. SATTER S, Gastanaduy P, Islam K, Rahman M, et al
     Hospital-Based Surveillance for Rotavirus Gastroenteritis among Young Children in Bangladesh: Defining the Potential Impact of a Rotavirus Vaccine Program.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
111. GRUBER JF, Hille DA, Liu GF, Kaplan SS, et al
     Heterogeneity of Rotavirus Vaccine Efficacy among Infants in Developing Countries.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
112. KARA EO, Campbell H, Ribeiro S, Fry NK, et al
     Survey of Household Contacts of Infants with Laboratory Confirmed Pertussis Infection During a National Pertussis Outbreak In England and Wales.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
113. MAMMEN VG, Dangor Z, Moore DP, Izu A, et al
     Hospitalization for Culture-Confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
114. VESIKARI T, Silfverdal SA, Jordanov E, Feroldi E, et al
     A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3, 5 and 11-12 Month Schedule.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
115. ZHU F, Deckx H, Roten R, Michiels B, et al
     Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene(R) TF and Engerix-B(R) Recombinant Hepatitis B Vaccines in Neonates in China.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
116. STRENG A, Grote V, Rack-Hoch A, Liese JG, et al
     Decline of Neurologic Varicella Complications in Children During the First 7 Years After Introduction of Universal Varicella Vaccination in Germany, 2005-2011.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
117. CIVEN R, Marin M, Zhang J, Abraham A, et al
     Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010.
     Pediatr Infect Dis J. 2016;35:1132-6.
     PubMed     Text format     Abstract available
     
     
     September 2016
118. TOLEDO ME, Casanova MF, Linares-Perez N, Garcia-Rivera D, et al
     Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre-Introduction of Pneumococcal Vaccination in Cuba.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
119. URUENA A, Gonzalez JE, Rearte A, Carrega ME, et al
     Single-Dose Universal Hepatitis A Immunization in One Year Old Children in Argentina: High Prevalence of Protective Antibodies Up to 9 Years Following Vaccination.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
120. WU D, Yen C, Yin ZD, Li YX, et al
     The Public Health Burden of Rotavirus Disease in Children <5 Years of Age and Considerations for Rotavirus Vaccine Introduction in China.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
121. PHILIP RK, Shapiro M, Paterson P, Glismann S, et al
     Is It Time For Vaccination To "Go Viral"?
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     August 2016
122. KAUR R, Casey JR, Pichichero ME
     Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
     Pediatr Infect Dis J. 2016;35:901-6.
     PubMed     Text format     Abstract available
     
     
     
123. CHIAPPINI E, Berti E, Sollai S, Orlandini E, et al
     Dramatic Pertussis Resurgence in Tuscan Infants in 2014.
     Pediatr Infect Dis J. 2016;35:930-1.
     PubMed     Text format    
     
     
     July 2016
124. HEMMING-HARLO M, Markkula J, Huhti L, Salminen M, et al
     Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for 5 Years After Universal RotaTeq(R) Vaccination in Finland.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
125. AABY P, Ravn H, Benn CS, Rodrigues A, et al
     Randomized Trials Comparing Inactivated Vaccine After Medium or High Titer Measles Vaccine with Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-Analysis.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
126. TAGARRO A, Bote P, Sanchez A, Otheo E, et al
     Complications of Pneumococcal Bacteremia After 13-Valent Conjugate Vaccine Withdrawal.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     June 2016
127. MO X, Tobe RG, Liu X, Mori R, et al
     Cost-Effectiveness and Health Benefits of Pediatric 23-Valent Pneumococcal Polysaccharide Vaccine, 7-Valent and Forecasting 13-Valent Pneumococcal Conjugate Vaccines in China.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
128. AABY P, Ravn H, Benn CS
     The WHO Review of the Possible Non-Specific Effects of Diphtheria-Tetanus-Pertussis Vaccine.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
129. REGAN AK, de Klerk N, Moore HC, Omer SB, et al
     Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A Retrospective Cohort Study.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
130. BETTINGER JA, Vanderkooi OG, Scheifele DW, Halperin SA, et al
     Do Dose Numbers Matter? Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
131. KITTIKRAISAK W, Suntarattiwong P, Ditsungnoen D, Klungthong C, et al
     Effectiveness of the 2013 and 2014 Southern Hemisphere Influenza Vaccines Against Laboratory-Confirmed Influenza in Young Children Using a Test-Negative Design, Bangkok, Thailand.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
132. WAGNER AL, Sun X, Huang Z, Ren J, et al
     On-Time Measles and Pneumococcal Vaccination of Shanghai Children: The Impact of Individual- and Neighborhood-Level Factors.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
133. SMEDEGAARD LM, Poulsen A, Kristensen IA, Rosthoj S, et al
     Varicella Vaccination of Children with Leukemia without Interruption of Maintenance Therapy - A Danish Experience.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
134. ARYA BK, Bhattacharya SD, Sutcliffe C, Niyogi SK, et al
     Impact of Haemophilus influenzae Type b Conjugate Vaccines (HibCV) on Nasopharyngeal Carriage in HIV Infected Children and Their Parents from West Bengal, India.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
135. OLBRICH P, Falcon-Neyra L, Molinos-Quintana A, Aguero-Sanchez M, et al
     First Documented Case of Influenza A (H3N2 Subtype) Infection in a Patient With Complete Interferon Gamma Receptor 1 Deficiency: A Call for Systemic Vaccination Strategies.
     Pediatr Infect Dis J. 2016;35:712-3.
     PubMed     Text format    
     
     
     May 2016
136. KUTER BJ, Brown M, Wiedmann RT, Hartzel J, et al
     Safety and Immunogenicity of M-M-R(R)II (Combination Measles-Mumps-Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
137. LOPEZ P, Lanata CF, Zambrano B, Cortes M, et al
     Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril(R)) when Administered Concomitantly with a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
138. LAMBERTI LM, Ashraf S, Walker CL, Black RE, et al
     A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
139. ZHU F, Hu Y, Li J, Ye Q, et al
     Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Compared With 7-Valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
140. FINN A, Morales-Aza B, Sikora P, Giles J, et al
     Density Distribution of Pharyngeal Carriage of Meningococcus in Healthy Young Adults: New Approaches to Studying the Epidemiology of Colonization and Vaccine Indirect Effects.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
141. SHRIVASTWA N, Gillespie BW, Lepkowski JM, Boulton ML, et al
     Vaccination Timeliness in Children under India's Universal Immunization Program.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
142. DITKOWSKY J, Kohlhoff S, Smith-Norowitz TA
     The Cost-Effectiveness of Varicella Zoster Virus Vaccination Considering Late Onset Asthma.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
143. ISLAM S
     Pediatric Latent Tuberculosis: Should Travel and Foreign Birth Testing Criteria be Reassessed?
     Pediatr Infect Dis J. 2016.
     PubMed     Text format    
     
     
     
144. GRANT LR, Hammitt LL, O'Brien SE, Jacobs MR, et al
     Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
145. WOO EJ, Winiecki SK, Arya D, Beeler J, et al
     Adverse Events After MMR or MMRV Vaccine in Infants Under 9 Months Old.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     
     
146. POYHONEN L, Pauniaho SL, Kroger L, Korppi M, et al
     Orthopedic Complications in Former Bacillus Calmette-Guerin Osteitis Patients.
     Pediatr Infect Dis J. 2016;35:579-80.
     PubMed     Text format     Abstract available
     
     
     
147. GAENSBAUER JT, Asturias EJ, Soto M, Holt E, et al
     Pediatric Invasive Pneumococcal Disease in Guatemala City: Importance of Serotype 2.
     Pediatr Infect Dis J. 2016;35:e139-43.
     PubMed     Text format     Abstract available
     
     
     April 2016
148. BRUUN T, Salamanca BV, Bekkevold T, Vainio K, et al
     Burden of Rotavirus Disease in Norway: Using National Registries for Public Health Research.
     Pediatr Infect Dis J. 2016;35:396-400.
     PubMed     Text format     Abstract available
     
     
     
149. ALMEIDA AF, Flor-de-Lima F, Simoes JS, Castro C, et al
     Pertussis in a Portuguese Pediatric Tertiary Care Hospital.
     Pediatr Infect Dis J. 2016;35:466-7.
     PubMed     Text format    
     
     
     
150. SHIN M, Salamanca BV, Kristiansen IS, Flem E, et al
     Healthcare Costs of Rotavirus and Other Types of Gastroenteritis in Children in Norway.
     Pediatr Infect Dis J. 2016;35:e97-e101.
     PubMed     Text format     Abstract available
     
     
     January 2016
151. SNAPE MD, Voysey M, Biostat M, Finn A, et al
     Persistence of Bactericidal Antibodies Following Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.
     Pediatr Infect Dis J. 2016.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: